{"url_path":"/sec/labt/8-k/2026-07-15/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-15","source_url":"https://www.sec.gov/Archives/edgar/data/2079272/0001213900-26-078328-index.html","accession_number":"0001213900-26-078328","cik":"0002079272","ticker":"LABT","issuer_name":"Lakewood-Amedex Biotherapeutics Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/2079272/0001213900-26-078328-index.html","primary_entity_key":"0002079272","primary_entity_name":"Lakewood-Amedex Biotherapeutics Inc."},"word_count":82,"has_tables":true,"body_markdown":"** **\n\n**Item 9.01 Financial Statements and Exhibits**\n\n** **\n\n(d) Exhibits\n\n \n\n**Exhibit\nNumber**\n \n**Description**\n\n99.1\n \n[Lakewood-Amedex Biotherapeutics Inc., Investor Deck, dated July 15, 2026](ea029796301ex99-1.htm)\n\n104\n \nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n1\n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities\nExchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n**LAKEWOOD-AMEDEX BIOTHERAPEUTICS INC.**\n\n \n \n \n\nDate: July 15, 2026\nBy:\n/s/ Kelvin Cooper\n\n \n \nKelvin Cooper\n\n \n \nChief Executive Officer\n\n \n\n2"}